Kaplan B, Pavel S, Uygut M, Tunc M, Eroksuz Y, Celik I
Vaccines (Basel). 2025; 13(2).
PMID: 40006716
PMC: 11861512.
DOI: 10.3390/vaccines13020169.
Shao Y, Wan T, Katie Chan K
Sci Rep. 2025; 15(1):4935.
PMID: 39929873
PMC: 11811167.
DOI: 10.1038/s41598-025-86698-1.
Zhang P, Xin M, Bai Y, Ren X, Li N
BMC Pediatr. 2025; 25(1):63.
PMID: 39871225
PMC: 11771022.
DOI: 10.1186/s12887-025-05436-8.
Lopez D, Zumarraga J
Int J Mol Sci. 2025; 25(24.
PMID: 39769240
PMC: 11678114.
DOI: 10.3390/ijms252413477.
Chiang Y, Jiang R
SAGE Open Med. 2024; 12:20503121241301894.
PMID: 39611127
PMC: 11603462.
DOI: 10.1177/20503121241301894.
Cross-Section of Neurological Manifestations Among SARS-CoV-2 Omicron Subvariants-Single-Center Study.
Jachman-Kapulka J, Zinczuk A, Simon K, Rorat M
Brain Sci. 2024; 14(11).
PMID: 39595924
PMC: 11591697.
DOI: 10.3390/brainsci14111161.
Genomic epidemiology and evolutionary dynamics of the Omicron variant of SARS-CoV-2 during the fifth wave of COVID-19 in Pakistan.
Razzaq A, Disoma C, Iqbal S, Nisar A, Hameed M, Qadeer A
Front Cell Infect Microbiol. 2024; 14:1484637.
PMID: 39502171
PMC: 11534695.
DOI: 10.3389/fcimb.2024.1484637.
In-silico evaluation of the T-cell based immune response against SARS-CoV-2 omicron variants.
Sharma S, Roy D, Cherian S
Sci Rep. 2024; 14(1):25413.
PMID: 39455652
PMC: 11511884.
DOI: 10.1038/s41598-024-75658-w.
Structural and genomic evolutionary dynamics of Omicron variant of SARS-CoV-2 circulating in Madhya Pradesh, India.
Dhankher S, Yadav P, Sharma S, Gupta E, Yadav R, Dash P
Front Med (Lausanne). 2024; 11:1416006.
PMID: 39323472
PMC: 11422100.
DOI: 10.3389/fmed.2024.1416006.
Drug susceptibility and the potential for drug-resistant SARS-CoV-2 emergence in immunocompromised animals.
Kiso M, Uraki R, Yamayoshi S, Imai M, Kawaoka Y
iScience. 2024; 27(9):110729.
PMID: 39280602
PMC: 11402253.
DOI: 10.1016/j.isci.2024.110729.
Depression, Anxiety, and Stress Among Chinese People During the Omicron Outbreak and Its Impact on Sleep Quality and Alcohol Dependency.
Ahmed M, Ahmed O, Hanbin S, Xie P, Jobe M, Li W
Alpha Psychiatry. 2024; 25(3):329-336.
PMID: 39148588
PMC: 11322709.
DOI: 10.5152/alphapsychiatry.2024.241574.
In vitro antibody-mediated SARS-CoV-2 infection suppression through human ACE2 receptor blockade.
Redd P, Merting A, Klement J, Poschel D, Yang D, Liu K
Immunol Lett. 2024; 268:106887.
PMID: 38925442
PMC: 11256821.
DOI: 10.1016/j.imlet.2024.106887.
High Transferability of Neutralizing Antibodies against SARS-CoV-2 to Umbilical Cord Blood in Pregnant Women Vaccinated with BNT162b2 XBB.1.5: A Retrospective Cohort Study.
Hayashi T, Sano K, Konishi I
Infect Dis Rep. 2024; 16(3):481-490.
PMID: 38920892
PMC: 11203347.
DOI: 10.3390/idr16030036.
VOE: automated analysis of variant epitopes of SARS-CoV-2 for the development of diagnostic tests or vaccines for COVID-19.
Lee D, Sangket U
PeerJ. 2024; 12:e17504.
PMID: 38912043
PMC: 11193398.
DOI: 10.7717/peerj.17504.
Tannic acids and proanthocyanidins in tea inhibit SARS-CoV-2 variants infection.
Chen C, Wang W, Wu C, Wang S, Chang W, Hung M
Am J Cancer Res. 2024; 14(5):2555-2569.
PMID: 38859869
PMC: 11162682.
DOI: 10.62347/QJBG3026.
COVID-19 in the Arab countries: Three-year study.
Alwahaibi N, Al Maskari M, Al-Jaaidi S, Al Dhahli B, Al Issaei H, Al Bahlani S
F1000Res. 2024; 12:1448.
PMID: 38854702
PMC: 11157493.
DOI: 10.12688/f1000research.142541.3.
Antigenic Characterization of Circulating and Emerging SARS-CoV-2 Variants in the U.S. throughout the Delta to Omicron Waves.
Di H, Pusch E, Jones J, Kovacs N, Hassell N, Sheth M
Vaccines (Basel). 2024; 12(5).
PMID: 38793756
PMC: 11125585.
DOI: 10.3390/vaccines12050505.
High interleukin-6 levels induced by COVID-19 pneumonia correlate with increased circulating follicular helper T cell frequency and strong neutralization antibody response in the acute phase of Omicron breakthrough infection.
Kawasuji H, Morinaga Y, Nagaoka K, Tani H, Yoshida Y, Yamada H
Front Immunol. 2024; 15:1377014.
PMID: 38694512
PMC: 11061453.
DOI: 10.3389/fimmu.2024.1377014.
Detection of SARS-CoV-2 B.1.1.529 (Omicron) variant by SYBR Green-based RT-qPCR.
Abdel-Sater F, Makki R, Khalil A, Hussein N, Borghol N, Khattar Z
Biol Methods Protoc. 2024; 9(1):bpae020.
PMID: 38680163
PMC: 11055497.
DOI: 10.1093/biomethods/bpae020.
Engineered Multivalent Nanobodies Efficiently Neutralize SARS-CoV-2 Omicron Subvariants BA.1, BA.4/5, XBB.1 and BQ.1.1.
Wang J, Shi B, Chen H, Yu M, Wang P, Qian Z
Vaccines (Basel). 2024; 12(4).
PMID: 38675799
PMC: 11054741.
DOI: 10.3390/vaccines12040417.
